Sign in
4

Changes in Ownership

Kalaris Therapeutics, Inc. Filed Acc 0001209191-23-053349

Chief Executive Officer sold 8,581 shares at $1.58 ($13,558)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Brainard Diana · Chief Executive Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2023-10-19 Sale : show line 1 in the form 10b5-1 −8,581 $1.58 $13,558 881,977 D
Open-market sales · 8,581 sh · avg $1.58 · $13,558
Loading xslF345X05/doc4.xml…